Network origin in Mike Holfinger first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 32 | |
| Subsidiary | Pharmaceuticals: Major | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Mike Holfinger via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Treasurer General Counsel Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer General Counsel | |
| INTUITIVE SURGICAL, INC. | Medical Specialties | Director/Board Member | |
| RIGEL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| SEAGEN INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| JPMORGAN CHASE & CO. | Major Banks | Corporate Officer/Principal Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Director/Board Member Chief Tech/Sci/R&D Officer | |
| HUMANIGEN, INC. | Biotechnology | Chief Executive Officer Chairman | |
| PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
| KYTHERA BIOPHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Founder | |
| CONCERT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| ANAPTYSBIO, INC. | Biotechnology | Director/Board Member Chairman | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Chairman Director/Board Member Director/Board Member | |
SillaJen Biotherapeutics, Inc.
 SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services SillaJen Biotherapeutics, Inc. develops and commercializes cancer therapeutics. It focuses on the development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for solid tumors. It is focused on two main programs, lead product candidate, which is in mid-stage clinical development for the treatment of advanced primary liver cancer and colorectal cancer and JX-929 which is under investigation for a variety of other solid tumors. The company was founded by John C. Bell and David H. Kirn in 2006 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| ADAMAS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Operating Officer General Counsel | |
DNAtrix, Inc.
 DNAtrix, Inc. Electronic Equipment/InstrumentsElectronic Technology DNAtrix, Inc. operates as a biotech company which focuses on the development of oncolytic viruses for cancer. The firm’s offers DNX-2401 product which is an oncolytic virus designed specifically for treating Glioblastoma. It also works to expand its platform technology for treating other cancers, including ovarian, prostate and pancreatic cancer indications. The company was founded in 2005 by Francis Patrick McCormick, Alfred Yung, Charles Conrad, Cande Gomez-Manzano and Juan Fueyo and is headquartered in Houston, TX. | Electronic Equipment/Instruments | Director/Board Member Chief Executive Officer | |
| ATRECA, INC. | Biotechnology | Director of Finance/CFO Chief Executive Officer General Counsel | |
| Stanford University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Agensys, Inc.
 Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Iowa State University | College/University | Undergraduate Degree Doctorate Degree | |
| Rutgers State University of New Jersey | College/University | Masters Business Admin Undergraduate Degree | |
| University of California, Berkeley | College/University | Graduate Degree Graduate Degree Undergraduate Degree | |
| University of Michigan | College/University | Masters Business Admin Graduate Degree Undergraduate Degree | |
Los Angeles Opera Co.
 Los Angeles Opera Co. Miscellaneous Commercial ServicesCommercial Services Los Angeles Opera Co. promotes and supports culture, education and sciences. Its educational programs include discounts on matinees, lessons for families, senior citizens, students, and teachers. The company was founded in 1986 and is headquartered in Los Angeles, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| ANACOR PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
| CYCLACEL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| California Institute for Regenerative Medicine | General Government | Director/Board Member Director/Board Member | |
| RELYPSA INC | Pharmaceuticals: Major | Chairman Investor Relations Contact Chief Executive Officer General Counsel | |
| GLOBAL BLOOD THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer General Counsel | |
| UNITY BIOTECHNOLOGY, INC. | Biotechnology | Chairman | |
| Anderson School of Management | College/University | Masters Business Admin | |
| SIENNA BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman | |
Sanifit Therapeutics SA
 Sanifit Therapeutics SA BiotechnologyHealth Technology Sanifit Therapeutics SA develops pharmaceuticals for calcification disorders. Its pipeline consists of treatments for calcification disorders, such as calciphylaxis and osteoporosis. The company was founded by Felix Grases in 2004 and is headquartered in Palma de Mallorca, Spain. | Biotechnology | Director/Board Member |
Statistics
International
| United States | 49 |
| Spain | 2 |
Sectoral
| Health Technology | 34 |
| Consumer Services | 7 |
| Commercial Services | 6 |
| Finance | 2 |
| Distribution Services | 2 |
Operational
| Director/Board Member | 173 |
| Independent Dir/Board Member | 84 |
| Corporate Officer/Principal | 80 |
| Director of Finance/CFO | 37 |
| Undergraduate Degree | 36 |
Most connected contacts
| Insiders | |
|---|---|
| Nicholas G. Galakatos | 38 |
| Elizabeth Czerepak | 31 |
| Ted Love | 31 |
| Arlene Morris | 28 |
| Dan Spiegelman | 24 |
| John Orwin | 21 |
| Keith Leonard | 20 |
| Paul Cleveland | 18 |
| Hollings Renton | 17 |
| Krishna R. Polu | 16 |
| Herbert Cross | 14 |
| Sylvia R. Wheeler | 14 |
| Hironori Hozoji | 13 |
| Steven Love | 13 |
| Cynthia Smith | 13 |
- Stock Market
- Insiders
- Mike Holfinger
- Company connections
